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All bacteria form persisters, cells that are multidrug tolerant and therefore able to survive antibiotic
treatment. Due to the low frequencies of persisters in growing bacterial cultures and the complex
underlying molecular mechanisms, the phenomenon has been challenging to study. However,
recent technological advances in microfluidics and reporter genes have improved this scenario.
Here, we summarize recent progress in the field, revealing the ubiquitous bacterial stress alarmone
ppGpp as an emerging central regulator of multidrug tolerance and persistence, both in stochasti-
cally and environmentally induced persistence. In several different organisms, toxin-antitoxin mod-
ules function as effectors of ppGpp-induced persistence.Introduction
The frequent failure of antibiotic treatment is an acute public
health problem. The most apparent reason is that the successful
use of any therapeutic agent is compromised by the develop-
ment of bacterial resistance. Indeed, it was not long after the
beginning of the antibiotic era that the first resistant organisms
appeared (Abraham and Chain, 1940). It is now known that bac-
teria develop resistance toward most if not all antibiotics that are
used clinically. Moreover, the wide-ranging use of antibiotics in
the general population, agriculture, farming, and hospitals has
increased the rate with which multidrug-resistant bacteria
appear. Although antibiotic resistance is a major culprit, there
are less obvious reasons for antibiotics to fail. One reason is
that bacteria can escape the lethal action of antibiotics by
entering a physiological state in which the antibiotics do not kill
them, a phenomenon known as bacterial persistence. This phe-
nomenon was first observed by Joseph Bigger, who discovered
that penicillin often failed to sterilize flask cultures of exponen-
tially growingStaphylococcus aureus cells (Bigger, 1944). Bacte-
rial persistence can be quantified by following the killing kinetics
upon the addition of a bactericidal antibiotic to a growing culture.
As shown in Figure 1, addition of a bactericidal antibiotic rapidly
killed the vast majority of the cells in a growing bacterial cul-
ture. However, after a few hours of treatment, the killing rate
decreased dramatically. The tail of the killing curve revealed
that the clonal population contained rare cells that were transi-
tory tolerant to the drug and thereby managed to survive (Lewis,
2010). Here, the term ‘‘bacterial persistence’’ will refer to the
phenomenon that isogenic populations of antibiotic-sensitive
bacteria produce rare cells that transiently become multidrug
tolerant.
Bacterial persistence is distinct from antibiotic resistance in
the sense that, unlike resistant mutants, persister cells do not
proliferate in the presence of the bactericidal agent but,randomly in time, switch back to a growing state, as revealed
by the second slope of the biphasic killing curve (Figure 1).
Consequently, when the antibiotic was removed, the cells gave
rise to a population that was as sensitive as the original one
and produced a similarly small proportion of persister cells
(Keren et al., 2004a). This observation demonstrated that, as
opposed to resistance, persistence is a noninherited phenome-
non. The killing efficiencies of most of the clinically used antibi-
otics depend strongly on the physiological state of the target
bacterium. For instance, slow-growing (or dormant) bacteria
having a lowmetabolic activity are partly or completely refractory
to killing by most antibiotics. This is because antibiotics usually
kill bacteria by corrupting essential, active targets. In slow-
growing cells, these targets are recalcitrant to the inhibitory
action of the antibiotics and, hence, the bacteria become tempo-
rarily drug tolerant. Thus, it was proposed early on that persisters
are cells that have entered a state of low metabolic activity, here
referred to as dormant or slow-growing cells. Bigger’s findings
were largely ignored, but in the past decade a growing number
of reports have focused on the persistence phenomenon that
has been observed with all tested bacteria, including pathogens
(Lewis, 2010). Thus, the phenomenon may contribute signifi-
cantly to the failure to treat chronic and relapsing infections suc-
cessfully with antibiotics.
Genetic Basis of Bacterial Persistence
hipA, the First ‘‘Persister’’ Gene
It has been proposed that bacterial persistence reflects acci-
dental decline toward cell death (Nystro¨m, 2003). Another view
envisages that, while bacterial persistence is noninherited, the
propensity to form persister cells is nevertheless a genetically
evolved trait (Kussell and Leibler, 2005). Experimental support
for the latter view is gradually accumulating. In the 1980s, Harris
Moyed revisited the issue of antibiotic persistence by isolatingCell 157, April 24, 2014 ª2014 Elsevier Inc. 539
Figure 1. Killing Kinetics during Treatment
with a Bactericidal Antibiotic
(1) Lethal dose of a bactericidal antibiotic is added
at time zero to a growing population of sensitive,
genetically identical bacteria. The experiment re-
veals a characteristic biphasic killing curve. (2) The
slope of the initial phase reveals the susceptibility
of the bulk of the population. The initial log-linear
relationship reveals an exponential killing kinetics
(green line). (3) The slope of the second inactiva-
tion phase (red line) reveals the existence of a
persister subpopulation that is killed with a much
slower kinetics. Killing kinetics for a high persister
mutant (hip) strain producing a highly elevated
number of persisters is also shown (dark dashed
line). After removal of the antibiotic (pointed by the
arrow flanking the right panels), persister cells
resume growth and give rise to progeny cells that
are genetically identical to the cells of the original
population and, therefore, as drug-sensitive as
the original cells. The gray dashed line indicates
how a drug-resistant mutant strain would support
growth under these conditions. Adapted from
Lewis (2010).mutants from E. coli that reproducibly formed high frequencies of
persister cells (Moyed and Bertrand, 1983). Indeed, intermittent
application of high doses of bactericidal antibiotics to a popula-
tion of chemically mutagenized bacteria gave rise to the isolation
of stable hip (high persister) mutants (Moyed andBertrand, 1983;
Wolfson et al., 1990). Notably, one gain-of-function allele, called
hipA7, enhanced persistence up to 1,000-fold. This showed that
the level of persisters could be increased as a result of a heritable
mutation (Figure 1). The hipA7 allele consisted of two separate
nucleotide substitutions in hipA, a gene of 440 codons (Black
et al., 1991; Moyed and Broderick, 1986). The hipA gene is
preceded by hipB that encodes an autorepressor of hipBA
transcription (Black et al., 1991, 1994). Overproduction of HipA
inhibited cell growth by attenuation of translation, DNA repli-
cation, and transcription and strongly enhanced tolerance to
bactericidal antibiotics (Korch and Hill, 2006). HipB interacts
directly with HipA and inhibits its activity. These observations
led to the suggestion that hipBA constitutes a bona fide toxin-
antitoxin (TA) locus (Korch et al., 2003). The direct inhibition of
HipA by HipB and the reduced interaction between HipB and
HipA7 readily explained the hipA7 phenotype because it would
lead to hyperactivation of HipA that, in turn, would trigger persis-
tence (Rotem et al., 2010; Schumacher et al., 2009). However,
this explanation seemed at variance with the observation that
HipA7 was less toxic than wild-type HipA (Korch and Hill,
2006), and the molecular mechanism behind the phenotype of
the hipA7 allele was not fully explained. Later analysis revealed
that HipA is a eukaryote-like Ser/Thr kinasewhose kinase activity
was required for both inhibition of cell growth and the stimulation
of persister cell formation (Correia et al., 2006). We and others
discovered recently that HipA inactivated glutamyl tRNA synthe-
tase (GltX) by phosphorylation (Germain et al., 2013; Kaspy et al.,
2013). Inhibition of GltX stimulated accumulation of uncharged540 Cell 157, April 24, 2014 ª2014 Elsevier Inc.tRNAGlu and synthesis of ppGpp. In
turn, the high level of ppGpp dramatically
increased the persistence level (Germainet al., 2013). These observations raised the obvious and impor-
tant question of how ppGpp mediates persistence.
Toxin-Antitoxins and Persistence
Since the discovery of hipA as a bona fide persister gene,
numerous research articles support the notion that persistence
of the model organism Escherichia coli depends on TA loci
(Do¨rr et al., 2010; Keren et al., 2004b; Maisonneuve et al.,
2011; Shah et al., 2006; Va´zquez-Laslop et al., 2006). Prokary-
otic TA loci code for two components, a stable ‘‘toxin’’ (always
a protein) that inhibits cell growth and a labile ‘‘antitoxin’’ (either
RNA or protein) that regulates toxin activity. The genetic archi-
tecture and the nature of regulation of TA activity gave rise to di-
vision of TAs into five classes. Type I and III TA loci encode small
RNA antitoxins that counteract the toxins at the translational
(antisense RNA) or posttranslational levels (direct toxin binding),
respectively. Type II TA loci encode an antitoxin protein that
combines with and neutralizes the toxin by direct interaction. A
general organization and regulation of type II TA loci is presented
in Figure 2. In type IV TAs, the antitoxins protect the toxin targets
instead of inhibiting the toxin directly (Masuda et al., 2012). Type
V antitoxins are site-specific endoribonucleases that inhibit toxin
expression by cleavage of toxin-encoding mRNAs (Wang et al.,
2012). In this Review, we will mainly focus on the role of type II
TA loci in persistence. Interestingly, ectopic overproduction of
type II toxins not only very efficiently inhibited cell growth, but
also induced a nongrowing state from which the cells could be
rapidly resuscitated by the induction of cognate antitoxin genes
(Christensen-Dalsgaard and Gerdes, 2006; Christensen-Dals-
gaard et al., 2010; Pedersen et al., 2002). Because of the ability
to severely inhibit cell growth, it has been of particular interest to
identify the cellular targets of the toxins. The targets of the toxins
that have been identified are summarized in Figure 2. Important
in this context, several reports showed that overproduction of
Figure 2. Canonical Type II Toxin: Antitoxin Genes and Their Cellular Targets
Schematic showing the genes and control loops of a canonical type II TAmodule. The protein antitoxin neutralizes the toxin by forming a tight complex with it. The
TA operon is repressed by the antitoxin and by the TA complex. When the level of free toxin is low, the TA complex binds strongly and cooperatively to the
promoter region and inhibits transcription. In contrast, transcription is derepressed by an excess of free toxin, a regulatory mechanism called conditional co-
operativity (Overgaard et al., 2009). The antitoxins are degraded by cellular proteases (Lon or Clp). Hence, protease activity controls toxin activity by determining
the level of antitoxin.
Cellular targets of the main toxins are shown in the right panel. (1) RelE inhibits translation by cleavage of mRNA at the ribosomal A site (Christensen and Gerdes,
2003). (2) MazF cleaves mRNAs in single-stranded regions (i.e., MazF, MqsR, HicA) (Christensen-Dalsgaard et al., 2010; Jørgensen et al., 2009; Zhang et al.,
2003). (3) Enteric VapCs inhibit translation by cleavage of intitiator tRNAfMet (Winther and Gerdes, 2011). (4) VapC20 of M. tuberculosis inhibits translation by
cleavage of the Sarcin-Ricin loop of 23S rRNA (Winther et al., 2013). (5) HipA of E. coli inhibits translation by phosphorylation of glutamyl-tRNA synthetase
(Germain et al., 2013). (6) Doc of prophage P1 inhibits translation by phosphorylating EF-Tu (Castro-Roa et al., 2013). (7) CcdB (aMazF homolog) and ParE (a RelE
homolog) inhibit DNA replication by inhibiting DNA gyrase (Bernard and Couturier, 1992; Jiang et al., 2002).type II toxins dramatically increased persistence (Keren et al.,
2004b; Maisonneuve et al., 2011; Shah et al., 2006; Va´zquez-
Laslop et al., 2006). That TA genes might be involved in persis-
tence was further supported by the finding that TA mRNAs
were among the most upregulated transcripts in the persister
fraction isolated from a hipA7 mutant (Keren et al., 2004b). A
similar TAmRNA profile was observed in dormant cells collected
from a growing population of wild-type E. coli cells by cell sorting
(Shah et al., 2006). These observations prompted a genetic anal-
ysis of the 11 known type II TAs in E. coli (all of which encode
mRNases except hipBA): deletion of any one of these loci had
minor effects on the persistence level of planktonic E. coli cells
(Keren et al., 2004b; Kim and Wood, 2010; Maisonneuve et al.,
2011). By contrast, deletion of all 10 mRNase-encoding type II
TA loci dramatically reduced persistence, showing that TA loci
contribute cumulatively to persistence (Maisonneuve et al.,
2011). Mathematical modeling of the connection between TAs
and persistence supported this interpretation (Fasani and
Savageau, 2013). In contrast, only one type I TA system has
been shown to influence persister cell formation directly (Do¨rr
et al., 2010).
Mechanisms of Persister Cell Formation
Stochastic Formation of Persister Cells: A Bet-Hedging
Strategy
Adaptive mechanisms have evolved to sense harmful environ-
mental conditions and enable cells to respond adequately to
mitigate the detrimental effects. Nevertheless, a pre-existing
phenotypic diversity (i.e., mixture of distinct phenotypes) that
confers fitness advantages under specific harmful condition
would provide another solution to survive fluctuating environ-
ments (Kussell and Leibler, 2005). Such types of cellular hetero-
geneity are often referred to as bet-hedging strategies (Dubnauand Losick, 2006; Veening et al., 2008). To elucidate the nature
of bacterial persistence, it was crucial to know whether persister
cells differ from others cells before exposure to antibiotics. Due
to the tiny frequency of persister cells in a bacterial population
(between 106 and 104), this task has been challenging to
achieve. However, the last decade has seen the development
of powerful tools that have enabled the analysis of single cells
en mass by microscopy, thereby surmounting the limits associ-
ated with observations of ensembles of cells. In particular, these
technological advances have enabled the identification and
analysis of very rare cells that are phenotypically different from
the main population. First, Stanislav Leibler and colleagues
investigated the persistence of E. coli at the level of single cells
(Balaban et al., 2004). Using fluorescent-based microscopy
combined with microfluidics, they were able to record the
behavior of individual cells before, during, and after treatment
by a b-lactam antibiotic (ampicillin) and subsequently follow
the genealogy of the persister cells. Such measurements were
made possible only by the use of a hipA7 mutant of E. coli that
produces 1,000-fold increased level of persisters (Balaban
et al., 2004). This approach validated Bigger’s initial hunch
that persisters comprise a pre-existing subpopulation that are
temporarily in a slow or nongrowing state and are thereby
tolerant to bactericidal antibiotics (Balaban et al., 2004). These
observations refuted the hypothesis that E. coli persisters
are mainly formed as a response to antibiotics and raised the
important question of the underlying molecular mechanism.
It is well known that all cells are subjected to both intrinsic and
extrinsic molecular noise that influences gene expression in indi-
vidual cells (Elowitz et al., 2002). However, noise by itself is not
able to trigger pronounced phenotypic diversity unless regulato-
ry enhancement processes (i.e., positive feedback) are involved
(Eldar and Elowitz, 2010). This so-called noise amplificationCell 157, April 24, 2014 ª2014 Elsevier Inc. 541
Figure 3. Mechanism underlying ppGpp-
Controlled Bacterial Persistence
(A) Time-lapse microscopy experiment showing
that single E. coli cells with a high level of
[ppGpp] as revealed by expression of the
‘‘ppGpp-proxy’’ RpoS-mCherry survive antibiotic
treatment.
(B) Current model for how ppGpp stochastically
induce persistence in E. coli. (1) Activation of
RelA or SpoT in single cells promotes accumu-
lation of ppGpp. (2) The ppGpp-dependent inhi-
bition of exopolyphosphatase (PPX), the cellular
enzyme that degrades PolyP, promotes PolyP
accumulation by the constitutively active poly-
phosphate kinase (PPK). (3) PolyP combines with
and stimulates Lon to degrade all 11 type II
antitoxins of E. coli K-12. (4) Free and activated
toxins inhibit translation and cell growth and
thereby induce persistence. (5) Speculative
positive-feedback loop that ensures even more
synthesis of ppGpp. The model predicts that
degradation of HipB enables free HipA to phos-
phorylate glutamyl-tRNA synthetase (GltX) and
inhibits charging of tRNAGlu. The resulting un-
charged tRNAs enter the ribosomal A site and
trigger RelA-dependent synthesis of (p)ppGpp.
Adapted from Germain et al. (2013) and Mai-
sonneuve et al. (2013).process leads to the emergence of bistability (or metastability):
that is, the establishment of two (or more) phenotypically stable
subpopulations of cells that coexist in a genetically identical
population. Moreover, heterogeneity may exist even within
such subpopulations, thereby possibly explaining that persister
subpopulations generated by similar underlying molecular
mechanisms may exhibit antibiotic-specific levels of persis-
tence.
Theoretical and experimental single-cell analysis of hipBA
showed that a threshold level of HipA was necessary to induce
dormancy. Moreover, the quantity by which this threshold was
surpassed determined the time of HipA-induced dormancy
(Rotem et al., 2010). Thus, fluctuations of toxin levels above
and below the threshold determine the onset as well as the dura-
tion of growth arrest, resulting in the co-occurrence of dormant
and growing cells. Moreover, mathematical simulations of type
II TAs indicated that their general architecture and regulation
(Figure 2) provide the potential for a robust stochastic switch
between the ON andOFF states. This switch can be driven either
by the proteolysis of the antitoxin, stochastic fluctuation or by
any change in the growth rate (Cataudella et al., 2012, 2013; Fa-
sani and Savageau, 2013; Gelens et al., 2013; Lou et al., 2008).
Moreover we and others described that transcription of evolu-
tionary independent TA operons, such as relBE, vapBC, and
phd/doc, is regulated by a phenomenon called conditional coop-
erativity. As described further below, conditional cooperativity
refers to the ability of a given toxin to act as both a corepressor
and a derepressor of its own TA operon (Afif et al., 2001; Garcia-
Pino et al., 2010; Overgaard et al., 2008; Winther and Gerdes,
2012) (Figure 2). It is thus possible that conditional cooperativity
provides a means of tight control of the bistable switch to gene
expression and toxin activation (Cataudella et al., 2013).542 Cell 157, April 24, 2014 ª2014 Elsevier Inc.A Model for Stochastic Induction of Bacterial
Persistence in E. Coli
We addressed recently the question of whether TA activation in a
small fraction of cells could be connected to persister formation.
Using transcriptional fusions between two representative TA loci
(relBE and yefM yoeB) and gfp, we discovered that TA operon
transcription was stochastically turned on at low frequencies in
exponentially growing E. coli cells (Maisonneuve et al., 2013).
The switching rate was similar to that of the frequency of persis-
tence. Usingmicrofluidics and fluorescent reporter gene fusions,
we established that the TA operon ON cells were phenotypically
associated with cessation of growth. These rare cells were
tolerant to high doses of b-lactam antibiotic and could resume
growth once the drug was removed (Maisonneuve et al., 2013).
These observations established that the toxins encoded by TA
genes are the effectors of bacterial persister cell formation.
We also established that ppGpp, the common regulator of the
bacterial stringent response, controls E. coli persister formation
by stochastically switching to a high level in single cells (Maison-
neuve et al., 2013) (Figure 3). We then uncovered a linear, hierar-
chical signaling pathway connecting TA activity to ppGpp that
invokes inorganic polyphosphate (PolyP) and Lon protease as
explained in detail in Figure 3 (Maisonneuve et al., 2013; Maison-
neuve et al., 2011).
RelA (the main enzyme responsible for ppGpp accumulation
during amino acid starvation in E. coli) is positively stimulated
by ppGpp, its own product (Shyp et al., 2012). Predictably,
such positive feedback would sustain rapid increases of [ppGpp]
that, in turn, would amplify both intrinsic (i.e., transcription and
translation rates) and extrinsic noise (fluctuations of [PolyP]
and thereby in Lon activity) that could activate toxins and thereby
contribute to persister cell formation (Figure 3). The fact that no
Figure 4. Overview of Physiological and Environmental Cues Stimulating Persister Cell Formation
(1) Bacterial persisters can arise stochastically in unstressed bacterial cultures as a bet-hedging strategy. (2) Environmental insults (i.e., starvation, oxidative and
acid stress, heat shock) provoking persister cell formation. (3) Social engagement through quorum sensing promotes persister cell formation. (4) Heterogeneous
and diffusion-limited biofilm microenvironments enhance persistence. (5) Host-pathogen interaction also induces formation of persisters.apparent environmental inputs were required for E.coli persister
formation raised the possibility that such cells were generated as
a consequence of purely random stochastic processes. Obvi-
ously this does not preclude a role for environmental factors in
persistence. In fact, external factors could have a modulatory
or a stimulatory effect on the rate of switching by affecting a
deterministic component. For instance, it is well established
that the fraction of persisters in cultures of both Gram-negative
andGram-positive bacteria increases substantially with cell den-
sity (Keren et al., 2004a; Maisonneuve et al., 2013). At stationary
phase, when the bacteria stop increasing in number, or when
growing in biofilm, at least 1% of the bacterial cells become anti-
biotic tolerant. Thus, we suggest that rare cells in exponentially
growing populations may encounter a ‘‘micro-starvation’’ envi-
ronment that triggers ppGpp synthesis and, thus, persister for-
mation (Maisonneuve et al., 2013).
Lon protease degrades all known antitoxins of E. coli K-12
(Gerdes and Maisonneuve, 2012), including HipB (Hansen
et al., 2012). Because HipA activation leads to ppGpp synthesis
(op. cit.), an increased level of HipA activity is predicted to
generate a positive-feedback loop that ensures even more syn-
thesis of ppGpp (Figure 3). This increase could also contribute to
stabilize the TAON state and could thereby prolong the persister
state. However, a hipBA deletion strain did not exhibit a reduced
level of persisters (Falla and Chopra, 1998; Hansen et al., 2008;
Korch et al., 2003), and more research is required to clarify this
issue.
Environmental Induction of Bacterial Persistence
A plethora of environmental signals increase persister levels
among isogenic bacterial populations. For instance, the fraction
of persisters increases during nutrient limitation and during dia-
uxic carbon-source transition (Amato et al., 2013; Bernier
et al., 2013; Fung et al., 2010; Keren et al., 2004a; Leung and Le´v-
esque, 2012; Nguyen et al., 2011). Pretreatment with subinhibi-
tory concentrations of antibiotics, oxidative stress, heat shock,
or DNA-damaging agents all increase antibiotic tolerance aspart of the bacterial adaptive response (Do¨rr et al., 2010; Leung
and Le´vesque, 2012; Mo¨ker et al., 2010; Vega et al., 2012; Wu
et al., 2012) (Figure 4).
Social engagements can promote cell individuality among
bacterial populations through chemical signaling communica-
tion, a phenomenon called quorum sensing (QS) (Bassler and
Losick, 2006). The strong increase in persistence as a bacterial
culture reaches late exponential phase resembles the dynamics
of QS (Keren et al., 2004a; Lewis, 2010). Interestingly, addition of
spent media from stationary cultures induced a significant in-
crease of persisters of a growing culture of P. aeruginosa, but
not of E. coli or S. aureus cultures (Mo¨ker et al., 2010). Indeed,
P. aeruginosa modulates the persister frequency in response
to the QS-signaling molecules pyocyanin and acyl-homoserine
lactone (Mo¨ker et al., 2010). However, deletion of the biosyn-
thetic pathway for pyocyanin had no effect on persister cell
formation, raising the possibility that additional or compensatory
signaling systems control the persister phenotype in this organ-
ism. In addition, the cariogenic organism Streptococcus mutans
generates persister cells that are positively influenced by the
stress-inducible QS pheromone peptide (CSP) (Leung and
Le´vesque, 2012) (Figure 4).
More recently, bacterial communication through indole was
suggested to induce persister cell formation in E. coli (Vega
et al., 2012). Indole, produced under nutrient-limited growth con-
ditions, altered the probability of a single cell to become persister
(Vega et al., 2012). Remarkably, indole also induced persister
formation in a Salmonella Typhimurium culture, even though
this bacterium does not normally produce indole. Thus, persister
modulation by chemical signaling is not limited to intraspecies
communication and could also confer a cross-species bet-
hedging strategy by interception of nonnative bacterial-signaling
molecules (Vega et al., 2013).
Signaling Pathways behind Induced Persistence
The ‘‘alarmone’’ ppGpp is almost ubiquitous in the bacterial
domain and plays a central role in environmentally inducedCell 157, April 24, 2014 ª2014 Elsevier Inc. 543
persister cell formation. It was discovered as the effector mole-
cule of the stringent response that is activated by a host of
different environmental stresses in almost all bacteria. In brief,
the stringent response reprograms cellular metabolism from
rapid to slow growth by simultaneously inhibiting and stimulating
the expression of 500 genes in E. coli (Durfee et al., 2008;
Traxler et al., 2008). Importantly, ppGpp binds directly to RNA
polymerase, thereby conferring inhibition of stable RNA (rRNA
and tRNA) promoters and stimulation of amino acid biosynthetic
promoters. ppGpp also stimulates accumulation of RpoS, the
master regulator of the general stress response. Many of these
changes also occur when bacteria enter stationary phase, and
in general, these response networks are essential for bacterial
survival and for virulence (Dalebroux et al., 2010). Interestingly,
when the two genes of E. coli coding for the enzymes that
produce ppGpp, relA and spoT (coding, respectively, for ppGpp
synthetases I and II), are deleted, persister cells become
extremely rare in exponentially growing planktonic cultures
(Korch et al., 2003; Maisonneuve et al., 2013). Moreover, basal
levels of ppGpp are required to sustain tolerance to cell-wall
active antibiotics of the Gram-positive pathogens E. faecalis
and S.aureus (Gaca et al., 2013; Geiger et al., 2014).
More recently, Amato et al. (2013) proposed a model explain-
ing how, in E. coli, the ‘‘ppGpp network’’ may lead to persistence
(Amato et al., 2013). Their model was derived from observations
seen under diauxie—that is, growth with two different carbon
sources, usually sugars. In the transition phase between the uti-
lization of two sugars, the cells elicited the stringent response
and ppGpp increased. In keeping with our model (Figure 3), Am-
ato et al. found that diauxie-induced persistence also depended
on ppGpp. However, the diauxie-induced persistence appeared
to be specific for a fluoroquinolone and depended on the
transcription factor DksA and nucleoid-associated proteins.
Because only single deletions of TA genes were tested, the study
was inconclusive as to the involvement of these genes in diauxie-
induced persistence.
During pathogenesis, bacteria often form biofilmswithin which
the bacterial cells are embedded in a three-dimensional matrix,
providing protection during harmful conditions. In biofilms, bac-
teria often encounter limited access to nutrients and therefore
elicit the stringent response (Figure 4). Consistently, multidrug
tolerance of P. aeruginosa and E. coli grown in biofilms de-
pended on ppGpp (Bernier et al., 2013; Maisonneuve et al.,
2013; Nguyen et al., 2011). Interestingly, the model proposed
by Nguyen and colleagues highlights an active mechanism
involving the stringent response (Nguyen et al., 2011). However,
it was not tested whether TAs were required for the ppGpp-
mediated increase in persistence. Importantly, we observed
that starvation failed to induce persistence in biofilms of E. coli
cells unable to activate stringent response, lacking PolyP, Lon,
or TA genes (Maisonneuve et al., 2013).
During pathogenesis, bacteria also encounter a variety of
stresses in their hosts that may trigger persister cell formation.
Single-cell microscopy of S. Typhimurium showed that, upon
macrophage phagocytosis, some bacteria initiated replication,
whereas others entered a nonreplicative state, even within the
same macrophage (Helaine et al., 2010). Part of these nonrepli-
cative cells were in a persister-like state that enabled them to544 Cell 157, April 24, 2014 ª2014 Elsevier Inc.survive long-term, host-induced damage and exposure to antibi-
otics (Helaine et al., 2014) (Figure 4). The Salmonella-containing
vacuoles of macrophages are relatively acidic and nutrient poor
(Dandekar et al., 2012). Consequently, bacteria within these vac-
uoles elicit the stringent response and become persisters
(Figure 4). Consistent with this conjecture, Salmonella mutants
impaired in the stringent response exhibited a highly reduced
macrophage-induced persister formation. Moreover, macro-
phage-induced persisters depended on both Lon protease and
TA genes (Helaine et al., 2014), thus lending support to the notion
that ppGpp-induced persister formation is not confined to E. coli.
Rather, these observations indicate that S. Typhimurium uses a
mechanism very similar to that of E. coli growing planctonically
to induce persisters (Maisonneuve et al., 2013). However,
unlike E. coli persisters, the Lon-dependent persister induc-
tion pathway of Salmonella responded specifically to signals
encountered within host cells (Helaine et al., 2014).
In addition to the stringent response, activation of the bacterial
SOS response, a signaling pathway that upregulates DNA repair
functions, appears to be associated with bacterial persistence.
Indeed, E. coli mutants with defects in SOS response genes
(i.e., lexA, recA, or recB) exhibited reduced persister levels
when treated with fluoroquinolones (Do¨rr et al., 2009). This
work also suggested an active and inducible mechanism of
persister formation mediated by the SOS response (Do¨rr et al.,
2009). Induction of the SOS response increased persistence to
fluoroquinolones dramatically. This increase depended on the
DNA-damage-inducible TisB toxin encoded by a type I TA locus
(Do¨rr et al., 2010). TisB is a small, 29 amino acid polypeptide that
associates with the cell membrane and decreases the proton
motive force and ATP levels (Unoson and Wagner, 2008). These
physiological effects may directly or indirectly lead to TisB-
dependent multidrug tolerance.
It has been proposed that generation of reactive oxygen spe-
cies (ROS) is central to cell killing by bactericidal antibiotics
(Kohanski et al., 2007; Kohanski et al., 2008). If true, mechanisms
that reduce the intracellular level of ROS should increase drug
tolerance. For instance, treatment with H2S, a gas known to
quench ROS production by iron ferrous sequestration, promotes
multidrug tolerance in a broad range of bacteria (Shatalin et al.,
2011). Moreover, activation of catalase, superoxide dismutase,
and antioxidant enzymes that are known to reduce cellular level
of ROS was associated with multidrug tolerance in planktonic
and biofilm associated bacteria. However, recent work demon-
strating that bacteriocidal antibiotics also kill bacteria under
anaerobic conditions is at variance with the hypothesis that
ROS are major killing agents generated by antibiotics (Keren
et al., 2013; Liu and Imlay, 2013). That ROS are dispensable
for the action of bactericidal antibiotics was supported by
several additional reports (Ezraty et al., 2013; Mahoney and
Silhavy, 2013). However, these observations are of course not
inconsistent with the proposal that ROS generated by antibiotics
interacting with their targets play a minor role in bacterial cell
killing.
Recently, it was reported that a subpopulation of
M. smegmatis cells survived treatment by the bactericidal drug
isoniazid (Wakamoto et al., 2013), a prodrug that requires activa-
tion by the bacterial enzyme catalase. Using microfluidics, these
authors elegantly showed that expression of catalase varied
stochastically in single cells. Thus, the surviving subpopulation
of bacteria was able to grow in the presence of isoniazid because
it did not activate the drug. We suggest that such drug escape is
better viewed as an atypical case of drug avoider, rather than
the multidrug tolerance phenotype exhibited by slow-growing
persister cells.
Resuscitation of Persistent Bacteria
To generate viable offspring, persister cells must be able to
resume growth. The rate of resuscitation of persisters is revealed
by the slope of the curve in the second phase of the classical
persister experiment shown in Figure 1. Ideally, the low killing
rate reflects the resuscitation rate because persisters reverting
to grow in the presence of the antibiotic are killed. The constant
rate of killing suggests that resuscitation is a stochastic event
occurring randomly in time (Rotem et al., 2010). The molecular
mechanisms behind the switching back to growth after
dormancy are largely unknown due mainly to the lack of experi-
mental approaches that can be employed to attack the problem.
Thus, at present, the mechanistic basis behind resuscitation of
persisters can only be speculated upon. In the persistent state,
the cellular translation rate is low. The low global translation
rate is assumed to support a high toxin/antitoxin ratio because
the antitoxins are less stable than the toxins. In turn, the T/A ratio
favors derepression of TA operon due to conditional cooperativ-
ity and sustains toxin production in persisters (Figure 2). Mathe-
matical modeling argued that conditional cooperativity may also
function to quench toxin activity rapidly when the signal (high
levels of ppGpp, or Poly(P)) that triggers antitoxin degradation
is diluted out (Cataudella et al., 2012, 2013). Neutralization of
the toxins, in turn, allows for resumption of cell growth.
Other active events may be required for a rapid quenching or
alteration of the original signal, and we speculate that inhibitors
of Lon, Poly(P), or ppGpp synthesis help persisters to resusci-
tate. We are currently addressing this possibility experimentally.
Obviously, a better understanding of the outgrowth mechanism
may facilitate the design of strategies that reduce persistence.
Clinical Relevance of Persister Cells
Given that persisters are produced bymany pathogenic bacteria
such as E. coli, S. aureus,M. tuberculosis, P. aeruginosa and the
fungus Candida albicans (Dhar and McKinney, 2007), the impli-
cations of microbial persistence to antibiotics failure are believed
to be significant. Theoretical arguments initially supported a role
for bacterial persistence in the outcome of antibiotic therapy.
Indeed, mathematical modeling predicted that persister cells
would (1) prolong the time before an infecting population of
bacteria is cleared and (2) preclude the eradication of infection
(Levin and Rozen, 2006). As described previously, Harris Moyed
observed that repetitive application of high doses of bactericidal
antibiotics to a population of mutagenized E. coli cells led to the
selection of hipmutants that stably produced increased levels of
persisters (Moyed and Bertrand, 1983). Because periodic appli-
cation of high doses of antibiotics is used routinely for treatments
of chronic infections, it was assumed that the emergence of hip
mutants could provide a selective advantage to the pathogens
andwould be causally connected to recalcitrance of the disease.Indeed, such hipmutants were selected in vivo during the course
of antimicrobial therapy in infections caused by C. albicans
(Lafleur et al., 2010) and P. aeruginosa (Mulcahy et al., 2010).
Thus, the persistence phenomenon undoubtedly underlies
many recurrent clinical infections. Furthermore, it was suggested
that persisters could support and even enhance the develop-
ment of heritable genetic resistance. Indeed, the same stress
response pathway that is important for the generation of per-
sisters can also accelerate random mutation or horizontal gene
transfer, thereby promoting the generation of antibiotic-resistant
mutants (Al Mamun et al., 2012; Beaber et al., 2004). The impor-
tance of persisters in the recalcitrance of infectious diseases
urges us to design new drug strategies to kill both actively
dividing cells and persisters effectively.
Eradication of Bacterial Persistence in Future
Treatment Regimens
As our mechanistic understanding of persister cell formation
expands, new strategies for tackling the problemmust be devel-
oped. As mentioned above, persisters are often functionally iso-
lated as slow-growing or dormant cells. Consequently, efforts
have been devoted to develop strategies that minimize hetero-
geneity by nudging resuscitation of dormant cells and thereby
rendering the bacterial population homogeneously susceptible
to antibiotics. Using metabolic network analysis, Collins’ group
found that simple sugars like mannitol, fructose, or glucose
in combination with gentamicin (a generic aminoglycoside
antibiotic) are able to decrease the number of persisters
by >1,000-fold in both Gram-negative (E. coli) andGram-positive
(Staphylococcus aureus) bacterial populations (Allison et al.,
2011). Interestingly, these metabolites did not restore normal
growth of persisters but instead energized the bacterial cell
membrane by increasing the proton motive force that, in turn,
increased the uptake rates of aminoglycosides. This metabolic
adjuvant approach is probably limited to aminoglycosides, as
the approach failed to reduce the level of cells tolerant to b-lac-
tam or fluoroquinolone antibiotics. Kim et al. (2011) used high-
throughput chemical screening for drugs that selectively kill
persisters without affecting normal growth of E. coli. This led to
the isolation of a compound that facilitated the killing of per-
sisters that survived ampicillin or ciprofloxacin treatments. The
compound considerably shortened the lag time needed for per-
sisters to resume growth after antibiotic exposure, suggesting
that it stimulates or accelerates reversion of persisters to antibi-
otic-sensitive cells.
Most bactericidal antibiotics kill bacteria by corrupting a
cellular target whose activity is required during active cell growth
(e.g., ampicillin kills bacteria by inhibiting cell-wall synthesizing
enzymes). An alternative approach is to use antibacterial com-
pounds that corrupt their cellular targets not only in growing
cells, but also in resting cells. Acyldeptipeptides represent a
class of antibiotics that activate ClpP, the core unit of a ubiqui-
tous bacterial protease complex (Bro¨tz-Oesterhelt et al., 2005).
Acyldeptipeptides bind directly to ClpP and unleash unregulated
and lethal protein degradation. By conjecture, such proteolytic
avalanche should be lethal also for nongrowing bacteria. Kim
Lewis’ group tested this inference and found that one such
acyldeptipeptide (ADEP4) produced complete eradication ofCell 157, April 24, 2014 ª2014 Elsevier Inc. 545
Staphylococcus aureus biofilms in vitro (Conlon et al., 2013).
Most importantly, when administered concomitantly with a con-
ventional antibiotic, ADEP4 cleared a deep-seated murine bio-
film infection caused by S. aureus (Conlon et al., 2013). Finally,
silver has been shown to enhance the action of conventional
antibiotics against Gram-negative bacteria both in vitro and
in a mouse biofilm infection model (Morones-Ramirez et al.,
2013). However, the practical implications of this discovery
remain to be seen, given that silver is a potent human poison.
Having shown that the stringent response is central to
persister induction and virulence, it is conceivable that inhibitors
of the stringent response could have therapeutic potentials. The
search for such potential inhibitors has already begun. For
instance, synthetic ppGpp analogs have been developed that
efficiently inhibit the ppGpp synthetase activity of Rel proteins
and thereby interfere with the long-term survival of Gram-posi-
tive bacteria (Wexselblatt et al., 2012).
Conclusions
Recent insights into bacterial persisters have revealed that mul-
tiple mechanisms underlie the phenomenon. Given the physio-
logical heterogeneity and complexity of each cell, it is evident
that persisters can emerge as a result of different tolerance-
associated mechanisms. However, the general involvement of
stress response pathways, in particular the stringent response,
suggests that persister formation is an evolved and deterministic
bet-hedging strategy used by bacteria to survive rapid and
potentially lethal environmental changes. So far, the majority of
studies have been restricted to the understanding of antibiotic
tolerance. Persisters are also tolerant to heavy metals (Harrison
et al., 2005), but the inference that persisters are tolerant to gen-
eral stresses, such as high osmolarity, heat, or extreme pHs,
remains to be examined.
The underlying cellular heterogeneity presents interesting
challenges for the development of sophisticated techniques to
study single-cell transcriptomics and metabolomics. Although
persisters are fundamentally distinct from resistant cells, the
stress responsemechanisms described here raise the possibility
that persisters contribute to or even enable relapsing and
chronic infections and may sustain the development of resis-
tance. Present and future insights into persister mechanisms
and the action of antibiotics will be used to develop clinical
methods to combat the consequences of this phenomenon.
Research on bacterial persistence may also assist the study of
other medical problems. For instance, similarly to bacteria, can-
cer cell populations exhibit heterogeneity, as revealed by the ex-
istence of slow-growing, drug-tolerant subpopulations that, after
treatment, may revert to the malignant, rapidly growing state
(Sharma et al., 2010). Thus, similar to bacteria, cancer cells
may exploit population heterogeneity to escape drug treatment.
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